Hrain Biotechnology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 260

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 19

Hrain Biotechnology General Information

Description

Researcher and developer of tumor immunotherapy technologies designed to provide treatments solutions for patients. The company uses tumor immunotherapy technology with their Chimeric Antigen Receptors T (CAR-T) products to provide cancer patients with precise care and treatment, enabling clinics and hospitals to utilize innovative medical development to provide better care and treatments for their patients.

Contact Information

Website
dashengbio.com
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Block D, 1F, Building 1, Lane 1238, Zhangjiang Road
  • Pudong New District
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Block D, 1F, Building 1, Lane 1238, Zhangjiang Road
  • Pudong New District
  • Shanghai, 201203
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hrain Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 14-Oct-2022 Announced Clinical Trials - Phase 3
6. Later Stage VC (Series C) 26-Apr-2021 Completed Startup
5. Secondary Transaction - Private 23-Dec-2020 Completed Startup
4. Later Stage VC (Series B1) 07-Sep-2020 Completed Startup
3. Early Stage VC (Series B) 13-Nov-2019 Completed Startup
2. Early Stage VC 24-Jul-2018 Completed Startup
1. Early Stage VC (Series A) 01-Mar-2018 Completed Startup
To view Hrain Biotechnology’s complete valuation and funding history, request access »

Hrain Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
To view Hrain Biotechnology’s complete cap table history, request access »

Hrain Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hrain Biotechnology Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing JunYuan Capital Investment Management Growth/Expansion Minority
Dingxiang Capital Venture Capital Minority
Herui Venture Capital Growth/Expansion Minority
October Assets Venture Capital Minority
Shaanxi Growth Enterprise Guide Fund Government Minority
You’re viewing 5 of 19 investors. Get the full list »

Hrain Biotechnology FAQs

  • When was Hrain Biotechnology founded?

    Hrain Biotechnology was founded in 2015.

  • Where is Hrain Biotechnology headquartered?

    Hrain Biotechnology is headquartered in Shanghai, China.

  • What is the size of Hrain Biotechnology?

    Hrain Biotechnology has 260 total employees.

  • What industry is Hrain Biotechnology in?

    Hrain Biotechnology’s primary industry is Drug Discovery.

  • Is Hrain Biotechnology a private or public company?

    Hrain Biotechnology is a Private company.

  • What is Hrain Biotechnology’s current revenue?

    The current revenue for Hrain Biotechnology is .

  • How much funding has Hrain Biotechnology raised over time?

    Hrain Biotechnology has raised $156M.

  • Who are Hrain Biotechnology’s investors?

    Beijing JunYuan Capital Investment Management, Dingxiang Capital, Herui Venture Capital, October Assets, and Shaanxi Growth Enterprise Guide Fund are 5 of 19 investors who have invested in Hrain Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process